Home/Filings/4/0001493152-23-021483
4//SEC Filing

HAMILTON JOHN F 4

Accession 0001493152-23-021483

CIK 0001614067other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:14 PM ET

Size

9.3 KB

Accession

0001493152-23-021483

Insider Transaction Report

Form 4
Period: 2023-05-04
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-055,0005,000 total
    Common Stock (5,000 underlying)
  • Award

    Stock Options

    2023-05-04+15,00076,540 total
    Exercise: $0.16Exp: 2033-05-04Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-05+5,0005,000 total
Footnotes (3)
  • [F1]50% of the options vest on the three month anniversary of the date of grant and the remainder vest on the six month anniversary of the date of grant.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]5,000 shares of Common Stock vested on June 5, 2023 and 5,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.

Documents

1 file

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1
  • filerCIK 0001252198

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:14 PM ET
Size
9.3 KB